Gene Query: SSBP1

Dataset Description Geneva Score
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 45.23
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 41.58
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 36.86
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 32.0
Co-transcriptional loading of RNA export factors shapes the human transcriptome 28.35
RNAseq of HEK293 cells after Chtop knockdown 28.35
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 23.0
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 21.79
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 21.63
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 19.36
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 19.28
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 19.28
Genome wide expression change in LCC2 and MCF-7 cells 17.97
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 17.45
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 17.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 17.37
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 17.37
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 17.36
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 17.36
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 16.36
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 16.34
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 16.31
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 16.25
ETV7 and interferon response 16.25
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 16.02
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 15.67
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 15.64
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 15.43
STRIPAK directs PP2A activity to promote oncogenic transformation 15.38
RNA-seq analysis of RALD iPSCs after in vitro differentiation 15.23
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 15.22
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 15.12
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 15.12
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 14.9
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.88
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.88
Systematic discovery of endogenous human ribonucleoprotein complexes 14.71
hnRNP C is a key regulator of protein synthesis in mitosis 14.7
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 14.48
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 14.48
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 14.09
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 14.09
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 13.6
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 13.55
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 13.55
Developmental stage specific chromosome architecture in human erythroid cells 13.55
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 13.28
Mapping interactions for the TNIP2 hub protein 13.21
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 13.15
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 13.15
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.82
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.82
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 12.8
3’ Uridylation Expands miRNA Target Repertoire 12.63
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 12.61
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 12.61
Total RNA-seq in ALL-SIL upon JQ1 inhibition 12.44
Effect of Influenza virus infection on lncRNA expression in A549 cells 12.38
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 12.17
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 12.04
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 12.04
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.02
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 12.01
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 11.92
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.89
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.89
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 11.79
The DPYSL2 gene connects mTOR and schizophrenia 11.56
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 11.52
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 11.35
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 11.35
FOXD3 is a novel tumor suppressor in lung cancer 11.34
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 11.29
Trans-differentiation of human adult peripheral blood T cells into neurons 11.23
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.21
Human HAP1 cells before and after nutrient deprivation 11.13
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 11.13
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.99
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 10.95
Transcriptional profiling of microglia; current state of the art and future perspectives 10.85
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 10.81
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 10.58
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.5
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.44
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 10.24
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 10.23
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.21
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 10.09
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 10.09
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 10.01
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 10.01
Mitochondrial dsRNA triggers antiviral signalling in humans 9.93
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.87
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.87
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.83
Global analysis of enhancer targets: Mosaic-seq 9.8
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.75
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.74
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.73
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.7
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 9.67
mRNA expression in human DAOY cells 9.66
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.64
Effect of BB608 on Gene Expression in HNSCC Cell Line 9.62
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.6
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 9.58
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 9.58
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.56
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.55
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.55
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.53
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 9.53
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 9.48
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.45
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 9.44
Regulation of protein translation during mitosis 9.38
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.33
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.33
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.3
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.29
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.28
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.27
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.25
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.24
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.24
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.23
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.2
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.18
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.17
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 9.15
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 8.98
Global expression profiles in cardiac progenitor cells generated by ISX-9 8.98
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 8.95
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 8.95
The landscape of alternative splicing in aggressive prostate cancers 8.94
Lysine benzoylation is a novel histone mark 8.92
Lysine benzoylation is a novel histone mark [RNA-seq] 8.92
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 8.86
Gene expression analysis of the impact of TDP-43 knockout in human cells. 8.84
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 8.81
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.81
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.79
Transcriptome analysis of H9 hESC derived cerebral organoids 8.77
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 8.71
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.71
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.64
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.63
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 8.61
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.56
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.55
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.54
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 8.47
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.44
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.44
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 8.43
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.43
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.38
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.38
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.37
CROP-Seq in Primary Human T Cells 8.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 8.35
RNA-sequencing of healthy human skeletal myocytes 8.33
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.25
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 8.24
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.22
RNA-seq analysis of BAP1-depleted uveal melanoma cells 8.19
Single-nucleotide-resolution mapping of HBV promoters using CAGE 8.18
RNA-seq of cells with TET1 knockout 8.16
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 8.15
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 8.13
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.13
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 8.12
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 8.12
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 8.12
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.1
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.06
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 8.06
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.05
Identification of renal resident macrophages across species 8.03
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.02
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.95
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 7.87
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.84
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.8
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.77
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.71
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.71
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.69
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 7.66
Transcriptomic analysis of the HOTAIR-regulated genes 7.62
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.6
Genome-wide discovery of human splicing branchpoints [RNAse] 7.6
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.56
Determination of tRNA aminoacylation levels by high throughput sequencing 7.55
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.5
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.49
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.49
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 7.49
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.48
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.47
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 7.45
Identifying the molecular mode of action of itraconazole in colorectal cancer 7.42
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.42
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.39
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 7.37
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 7.37
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.37
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.36
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 7.31
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.3
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 7.29
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 7.27
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.24
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.24
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.18
MCF-7 as a model for functional analysis of breast cancer risk variants 7.17
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 7.17
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 7.14
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.13
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 7.1
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 7.08
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.06
Ribosomal footprinting of CN34-Parental and CN34-LM1a 7.02
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.96
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.92
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 6.92
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.91
A549 cells and MSR-A549 cells 6.91
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.77
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.77
Triple vectors expand AAV transfer capacity in the retina 6.77
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.7
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 6.69
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 6.68
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 6.61
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 6.61
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.56
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 6.48
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 6.47
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 6.46
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.43
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.37
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.36
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 6.32
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.24
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.21
Identification of HOXB13 target genes responsive to BET inhibitors 6.21
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.21
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.19
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.19
Effect of FGF13 depletion on the H460 cell line 6.13
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 6.11
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 6.06
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.02
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 5.91
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.87
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.87
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.8
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 5.76
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 5.76
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.74
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.68
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.66
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.66
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 5.59
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 5.56
RNA sequencing of primary human platelets and in vitro cell lines 5.53
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.52
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.52
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.51
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.47
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.43
Transcriptional responses of melanoma cells to BRAF inhibition 5.34
Transcriptome analysis upon C6orf203 silencing 5.32
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.31
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.31
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.31
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 5.3
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 5.27
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.24
Gene expression in GBM with Cav3.2 inhibition 5.2
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.19
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.16
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.15
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.11
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 5.07
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 5.07
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 5.04
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.04
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.03
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.01
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 4.95
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 4.94
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 4.9
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 4.89
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.87
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.8
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 4.74
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.74
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 4.73
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.72
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.69
RNA seq with AML (NB4) cells upon FTO inhibition 4.68
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 4.63
Primary Human B-cell Temporal Response to CD40L Stimulation 4.63
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.62
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.62
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.62
miR941 overexpression experiment 4.6
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.6
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.55
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.53
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.45
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.42
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.42
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.37
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.37
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.36
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.34
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.28
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 4.28
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 4.28
The cohesin complex prevents Myc-induced replication stress 4.26
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.25
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.23
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.23
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.16
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.15
RNA-seq of RKO cells with cTAZ KO or putback 4.14
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.09
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.01
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.97
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.93
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.91
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.76
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.76
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.76
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.73
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.73
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.71
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.69
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.69
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.66
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.65
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.65
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 3.64
Solid phase chemistry to covalently and reversibly capture thiolated RNA 3.58
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.57
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.57
Regulatory network controlling tumor-promoting inflammation in human cancers 3.56
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.56
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.54
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.54
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.53
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.52
Effect of PRDM11 depletion in U2932 cells 3.48
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.42
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.41
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.38
Regulating Interleukin-2 activity with engineered receptor signaling clamps 3.34
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.33
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.31
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.31
Single-cell analysis of human kidney organoids 3.27
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.23
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.21
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.19
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.18
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 3.17
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 3.17
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.17
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.16
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.16
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 3.15
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.14
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.14
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.12
High-throughput sequencing of PROMPT-enriched samples. 3.05
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.03
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.03
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.02
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.87
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.82
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.81
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.81
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.72
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.65
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.61
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.57
Determining mRNA half-lives on a transcriptome-wide scale 2.55
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 2.54
Ribosome profiling upon inhibition of eIF4A 2.49
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.42
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 2.41
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.4
Induced DNA demethylation, genome instability and transcription 2.39
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.39
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.38
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.37
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.36
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.34
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.3
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.2
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 2.13
Function and hormonal regulation of GATA3 in human first trimester placentation 2.12
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.09
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.09
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.07
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.04
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.98
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.97
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.93
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.87
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.82
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.79
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.76
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.73
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.73
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.7
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.68
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.68
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.67
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.67
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.67
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.66
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.61
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.52
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.52
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.46
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.45
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.43
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.43
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.41
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.41
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.41
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.33
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.31
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.3
RNA-seq data 1.3
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.29
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.29
RNAseq of cell lines with knocked in ESR1 mutations 1.26
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.18
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.18
Iron response of HepG2 cells 1.13
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.13
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.11
Impact on erythroid progenitor type on erythroid differntiation 1.1
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.07
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.06
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.06
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.06
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.06
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.06
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.05
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.01
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.99
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.97
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.93
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.91
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.89
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.87
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.78
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.77
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.76
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.75
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.75
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.75
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.75
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.73
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.73
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.7
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.67
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.67
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.66
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.64
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.64
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.63
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.53
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.53
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.52
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.5
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.49
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.45
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.39
siRNA-mediated knockdown 0.39
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.36
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.3
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.3
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.3
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.27
Transcriptome-wide response to synthetic chromatin protein PcTF 0.26
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.2
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.2
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.19
Role of cervicovaginal microbiota in genital inflammation 0.15
Comparative Analysis of Cas9 Activators Across Multiple Species 0.12
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation